News | April 25, 2022
Global AYUSH meet ends with promise of Rs 9000 cr. in investment
Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal
Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal
The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle
CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
The organization has introduced an advanced FlashMicelle technology which is a combination of ultra-rapid mixing techniques, and a uniquely powerful approach to modify the structure of oil-based formulations to improve their therapeutic efficacy substantially
Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer
The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
Subscribe To Our Newsletter & Stay Updated
